Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Eye
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
About the society
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
May 2002, Volume 16, Number 3, Pages 242-260
Table of contents    Previous  Abstract  Next   Full text  PDF
Review
The pathogenesis of diabetic retinopathy: old concepts and new questions
J Cai and M Boulton

Department of Optometry and Vision Sciences Cardiff University, UK

Correspondence to: Professor M Boulton, Department of Optometry and Vision Sciences Cardiff University Redwood Building King Edward VII Avenue Cathays Park Cardiff CF10 3NB Wales, UK Tel: +44 (0)29 2087 5100 Fax: +44 (0)29 2087 4859 E-mail: BoultonM@cardiff.ac.uk

Abstract

Hyperglycaemia appears to be a critical factor in the aetiology of diabetic retinopathy and initiates downstream events including: basement membrane thickening, pericyte drop out and retinal capillary non-perfusion. More recently, focus has been directed to the molecular basis of the disease process in diabetic retinopathy. Of particular importance in the development and progression of diabetic retinopathy is the role of growth factors (eg vascular endothelial growth factor, placenta growth factor and pigment epithelium-derived factor) together with specific receptors and obligate components of the signal transduction pathway needed to support them. Despite these advances there are still a number of important questions that remain to be answered before we can confidently target pathological signals. How does hyperglycaemia regulate retinal vessels? Which growth factors are most important and at what stage of retinopathy do they operate? What is the preferred point in the growth factor signalling cascade for therapeutic intervention? Answers to these questions will provide the basis for new therapeutic interventions in a debilitating ocular condition.

Eye (2002) 16, 242-260. DOI: 10.1038/sj/eye/6700133

Keywords

diabetic retinopathy; hyperglycaemia; retina endothelial cells; pericytes; hypoxia; neovascularization; growth factor

May 2002, Volume 16, Number 3, Pages 242-260
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group